The European Commission has reportedly made arrangements with Pfizer Inc (NYSE: PFE) and various European pharmaceutical companies to secure the capacity to produce up to 325 million vaccines annually for potential future global health crises.
Under the agreement, companies will maintain their facilities in a state of readiness, monitor supply chains, and stockpile as needed, to enable rapid production if a new public health crisis arises, Reuters reported.
